Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early bactericidal activity of WX-081 in pulmonary tuberculosis
CTR20202011Phase 2Completed
- Sponsor
- Cisen Pharmaceutical Co., Ltd.
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sudapyridine in pulmonary tuberculosis (TB), sponsored by Cisen Pharmaceutical Co., Ltd.. Started Oct 2020; status: completed.
02
Drugs
sudapyridine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20202011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202011.